SURGICAL HEMOSTATS, INTERNAL TISSUE SEALANTS, AND ADHESION BARRIERS MARKET ANALYSIS

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type (Hemostats (Thrombin Based, Combination Hemostats, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based), Internal Tissue Sealants (Fibrin Based, Collagen Based, Protein Based, Synthetic Polymer Based), Adhesion Barriers (Film Based, Gel Based, Solution Based)), By Application (Surgical Applications (Cardiovascular Surgeries, Neurological Surgeries, Orthopedic Surgeries, Urological & Gynecological Surgeries, General Surgeries, Reconstructive, and Plastic Surgeries, Others), Trauma Cases), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2023
Code : CMI3721
Pages :171
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global surgical hemostats, internal tissue sealants, and adhesion barriers market over the forecast period. This is due to the increasing number of Small Bowel Obstruction (SBO) cases in the U.S. In order to prevent scar or adhesion formation in SBO, the use of an adhesion barrier is necessary which can drive growth of market. For instance, according to an article published by the Journal of Minimally Invasive Gynaecology, Small bowel obstruction is a major cause of postoperative mortality and morbidity following abdominal and pelvic surgery, with 225,000−345,000 annual admissions in the U.S. It accounts for 12–16% of emergency surgical admissions and 20% of emergency surgical procedures. Even with the advent of laparoscopic surgery, intra-abdominal adhesions remain a significant cause of SBO, accounting for 65% of cases.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market : Cross Sectional Analysis:

Increase in launches of new products in the Europe region is expected to drive the growth of the product type segment in this region. For instance, on February 26, 2020, Terumo Corporation, a Japan-based medical device company, launched a new surgical sealant Aquabrid in European Union which includes countries like France, Germany, Italy etc. The company further planned to launch products in Eastern Europe, the Middle East, and Africa.